What Life Insurance Blood Tests Check For

Life insurance blood tests are a comprehensive screening that provides carriers with an objective assessment of your health. Understanding what is tested helps you prepare for the exam and anticipate how results may affect your underwriting classification. The blood panel used in life insurance is more comprehensive than many routine medical checkups, giving underwriters a detailed picture of your metabolic health, organ function, and risk factors.

The standard blood panel includes a complete metabolic panel measuring glucose levels (screening for diabetes and pre-diabetes), liver function tests (ALT, AST, GGT — elevated levels can indicate liver disease, alcohol use, or medication effects), kidney function tests (BUN and creatinine — assessing kidney health), and electrolyte levels (sodium, potassium, chloride — indicating overall metabolic health). Each of these markers tells the underwriter something specific about your organ health and metabolic function, and abnormal results trigger further investigation.

A lipid panel measures total cholesterol, HDL (good cholesterol), LDL (bad cholesterol), and triglycerides. Carriers evaluate not just total cholesterol but the ratio between HDL and LDL, as this provides a more nuanced picture of cardiovascular risk. Favorable ratios can sometimes offset slightly elevated total cholesterol. For example, a total cholesterol of 250 with an HDL of 80 presents a lower cardiovascular risk than a total cholesterol of 220 with an HDL of 35. Underwriters at sophisticated carriers evaluate the complete lipid profile rather than focusing on a single number.

Additional screenings include a complete blood count (CBC) evaluating red and white blood cells and platelets, hemoglobin A1C (a three-month average of blood sugar levels, providing a more reliable diabetes indicator than a single glucose reading), cotinine levels (detecting nicotine and tobacco use), HIV antibody and antigen testing, hepatitis B and C screening, and prostate-specific antigen (PSA) for males over certain ages. The A1C test is particularly important because it cannot be influenced by fasting or one-day preparation — it reflects your true average blood sugar over the preceding three months.

Results that typically raise underwriting concerns include fasting glucose above 126 mg/dL (indicating potential diabetes), A1C above 6.5% (confirming diabetes), significantly elevated liver enzymes (especially GGT, which correlates with alcohol consumption), cotinine indicating tobacco use, and abnormal kidney function markers. Mildly abnormal results are common and do not necessarily result in a declined application — they may simply affect your risk classification. Underwriters distinguish between mildly elevated readings that suggest early-stage risk and significantly abnormal readings that indicate established disease.

Some blood test results are more heavily weighted than others in the underwriting process. Liver enzymes (particularly GGT) are scrutinized closely because elevated levels can indicate alcohol use, which carriers view as a mortality risk factor. The hemoglobin A1C is heavily weighted because it provides an objective, three-month average that the applicant cannot manipulate through short-term preparation. Cotinine is a binary indicator — any positive result at the carrier's threshold level triggers smoker classification.

If your blood test results are unexpected or seem inconsistent with your recent medical checkups, there may be a legitimate explanation. Laboratory variation between different labs, temporary illness effects, medication interactions, and fasting status can all influence results. If you have recent lab work from your physician that shows different values, providing those results to the underwriter (through your agent) can support a more favorable interpretation of the insurance lab results.

Understanding what blood tests check for also helps you take proactive steps to maintain good results over time. Regular physician visits with routine blood work, managing conditions consistently with prescribed medications, maintaining a balanced diet, and exercising regularly all contribute to blood test results that support favorable underwriting classifications. These are not short-term exam preparation strategies — they reflect the ongoing health management that carriers reward with better risk classifications.